Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1133931-73-3

Post Buying Request

1133931-73-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1133931-73-3 Usage

Description

Benzyl (2S)-5-[(benzyloxy)imino]-2-[(tert-butoxy)carbonyl]amino-6-chlorohexanoate is a complex organic compound with a unique molecular structure. It is characterized by its benzyl group, a phenylmethyl ester, and a chlorohexanoate backbone. benzyl (2S)-5-[(benzyloxy)imino]-2-[(tert-butoxy)carbonyl]amino-6-chlorohexanoate is known for its potential applications in various industries, particularly in the pharmaceutical sector.

Uses

1. Used in Pharmaceutical Industry:
Benzyl (2S)-5-[(benzyloxy)imino]-2-[(tert-butoxy)carbonyl]amino-6-chlorohexanoate is used as a reactant in the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a key component in the development of new drugs with potential therapeutic applications.
2. Used in Drug Synthesis:
Benzyl (2S)-5-[(benzyloxy)imino]-2-[(tert-butoxy)carbonyl]amino-6-chlorohexanoate is used as a building block for the creation of novel drug molecules. Its versatile structure enables chemists to modify and optimize its properties, leading to the development of more effective and targeted medications.
3. Used in Research and Development:
benzyl (2S)-5-[(benzyloxy)imino]-2-[(tert-butoxy)carbonyl]amino-6-chlorohexanoate is also utilized in research and development settings, where it can be studied for its chemical properties and potential interactions with biological systems. This knowledge can then be applied to the design of new drugs and therapies.
4. Used in the Synthesis of Avibactam:
Specifically, benzyl (2S)-5-[(benzyloxy)imino]-2-[(tert-butoxy)carbonyl]amino-6-chlorohexanoate is used as a reactant in the synthesis of Avibactam, an antibiotic that is part of a combination therapy for the treatment of bacterial infections.

Check Digit Verification of cas no

The CAS Registry Mumber 1133931-73-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,3,3,9,3 and 1 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1133931-73:
(9*1)+(8*1)+(7*3)+(6*3)+(5*9)+(4*3)+(3*1)+(2*7)+(1*3)=133
133 % 10 = 3
So 1133931-73-3 is a valid CAS Registry Number.

1133931-73-3Relevant articles and documents

Development of a Manufacturing Route to Avibactam, a β-Lactamase Inhibitor

Ball, Matthew,Boyd, Alistair,Ensor, Gareth J.,Evans, Matthew,Golden, Michael,Linke, Simon R.,Milne, David,Murphy, Rebecca,Telford, Alex,Kalyan, Yuriy,Lawton, Graham R.,Racha, Saibaba,Ronsheim, Melanie,Zhou, Shao Hong

, p. 1799 - 1805 (2016)

Process development work to provide an efficient, robust, and cost-effective manufacturing route to avibactam, a β-lactamase inhibitor is presented herewith. Aspects of this optimization work include the counterintuitive introduction of a protecting group to effect a difficult urea formation and the use of controlled feed hydrogenation conditions to facilitate an elegant one pot debenzylation and sulfation reaction. Overall, the commercial process delivers avibactam in much improved yield with significant reduction in the environmental footprint.

B-LACTAMASE INHIBITOR AND APPLICATION THEREOF

-

, (2018/03/07)

The present invention relates to a compound of Formula (I)-(IV) useful as β-lactamase inhibitor, a pharmaceutically acceptable salt, ester, solvate or stereoisomer thereof, wherein R1, R2, M and ring A have definitions as those in the specification. The present invention further relates to methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and uses of these compounds. For example, the compounds of the present invention can be used as β-lactamase inhibitors, for treatment and/or prophylaxis of diseases caused by bacterial infections, solving drug-resistance problems caused by β-lactamases, especially bacterial drug-resistant diseases caused by type B metallo-β-lactamases.

METHOD FOR PREPARING DISUBSTITUTED PIPERIDINE AND INTERMEDIATES

-

Page/Page column 3, (2010/08/08)

The disclosure relates to a method for preparing a compound of formula (I), wherein P1 and P2 are groups protecting the carboxylic acid and oxyamine functions, starting from pyroglutamic acid (S). The disclosure also relates to novel

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1133931-73-3